The long noncoding RNA TP73-AS1 promotes tumorigenicity of medulloblastoma cells

Int J Cancer. 2019 Dec 15;145(12):3402-3413. doi: 10.1002/ijc.32400. Epub 2019 Jun 12.


Medulloblastoma is the most common malignant brain cancer in children. Since previous studies have mainly focused on alterations in the coding genome, our understanding of the contribution of long noncoding RNAs (lncRNAs) to medulloblastoma biology is just emerging. Using patient-derived data, we show that the promoter of lncRNA TP73-AS1 is hypomethylated and that the transcript is highly expressed in the SHH subgroup. Furthermore, high expression of TP73-AS1 is correlated with poor outcome in patients with TP53 wild-type SHH tumors. Silencing TP73-AS1 in medulloblastoma tumor cells induced apoptosis, while proliferation and migration were inhibited in culture. In vivo, silencing TP73-AS1 in medulloblastoma tumor cells resulted in reduced tumor growth, reduced proliferation of tumor cells, increased apoptosis and led to prolonged survival of tumor-bearing mice. Together, our study suggests that the lncRNA TP73-AS1 is a prognostic marker and therapeutic target in medulloblastoma tumors and serves as a proof of concept that lncRNAs are important factors in the disease.

Keywords: gene regulation; oncogene; sonic hedgehog.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis / genetics
  • Biomarkers, Tumor / genetics
  • Cell Line, Tumor
  • Cerebellar Neoplasms / genetics*
  • Humans
  • Male
  • Medulloblastoma / genetics*
  • Mice
  • Mice, Inbred NOD
  • Mice, SCID
  • RNA, Long Noncoding / genetics*
  • Signal Transduction / genetics
  • Up-Regulation / genetics


  • Biomarkers, Tumor
  • RNA, Long Noncoding
  • long non-coding RNA KIAA0495, human